American Airlines, British Airways and oneworld have launched an optional Covid-19 medical-based testing trial on selected flights from the United States to London Heathrow.
It is being done in a combined effort to scientifically demonstrate how Covid-19 testing can reopen international travel and remove the need for passengers to quarantine on arrival.
The free tests will initially be offered to eligible customers booked on American Airlines flight AA50 departing Dallas/ Fort Worth (DFW) to LHR; British Airways flight BA114 departing New York’s John F. Kennedy Airport (JFK) to LHR; and British Airways flight BA268 from Los Angeles (LAX) to LHR, beginning 25 November.
The test will be expanded to American Airlines flight AA106 from JFK to LHR, with a launch date to come.
British Airways’ chief executive, Sean Doyle, said: “We know people want to travel but our skies remain all but closed and the UK is being left behind. Major economies like Germany are adopting testing to replace quarantine.
“We need the UK Government to introduce a system that allows travellers to take reliable, affordable tests before departure, so they are confident that fellow passengers are COVID-free. For people arriving from countries with high infection rates, a further test on arrival should then release them from quarantine.
“We are confident this approach would open routes, stimulate economies and get people travelling with confidence. The UK’s economic recovery depends on the swift reopening of its skies.”
Eligible customers booked on flights that are part of the trial will be contacted by American Airlines and British Airways with instructions on how to volunteer. Each customer participating in the trial will take three tests in conjunction with the journey. If a customer tests positive, they should reschedule or cancel their travel.
The first test, to be taken 72 hours before departure from the US, is an at-home RT-PCR test provided by LetsGetChecked. Customers will self-collect a nasal sample, under the supervision of medical professionals via a virtual visit.
After landing at LHR, participating customers will proceed to their second test at the airport. The LAMP test, provided by Collinson, involves the collection of a nasal sample by a medical professional. After the test is completed, a test kit for the third test will be provided to the customer. The test kit offers an at-home testing option, through the self-collection of a saliva sample which is taken three days after arrival in to the United Kingdom (UK).
The three-test approach aims to validate a customer’s negative status for Covid-19 throughout the travel journey. The third test is intended to further confirm the results of the first two tests, to demonstrate that one or two tests will be sufficient to allow travel to safely restart.
A task force comprising oneworld member airline representatives and independent medical experts are overseeing the implementation of the trial.
American Airlines, British Airways and oneworld will closely monitor customer participation. The task force will share aggregated results with the US and UK Governments and other stakeholders to demonstrate the essential role that Covid-19 testing programmes can play in safely restarting travel.
Based on current UK Government policies, international travellers arriving in the UK from the US are required to self-isolate for 14 days even if they have tested negative for Covid-19.
The tests being used as part of the trial will not impact UK National Health Service testing capacity.
British Airways and American Airlines have worked with Heathrow on implementation of the trial in to Terminal 5, and as a result Heathrow is now exploring whether trials can be introduced on more routes between the airport and the US.
Chairman and chief executive of American Airlines, Doug Parker, added: “American has already successfully introduced a pre-flight COVID-19 testing programme for customers travelling from the US to international destinations across the Caribbean and Latin America. We have received tremendous feedback from our customers in response to testing, as it provides peace of mind for safe and enjoyable travel.
“The UK is a critically important business and leisure destination that our customers want to visit. We believe the results provided by this trial will be vital for reopening transatlantic travel safely.”